iodixanol has been researched along with Glioblastoma in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frehtman, V | 1 |
| Wohlfarth, D | 1 |
| Müller, M | 1 |
| Krebs, O | 1 |
| Leuchs, B | 1 |
1 other study available for iodixanol and Glioblastoma
| Article | Year |
|---|---|
Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application.
Topics: Glioblastoma; H-1 parvovirus; Humans; Oncolytic Virotherapy; Oncolytic Viruses; Pancreatic Neoplasms | 2023 |